Dr Ananth S Mathad, a specialist doctor with nearly 20 years of distinguished service in the medical field, has newly joined ...
PLT012, a groundbreaking anti-CD36 antibody, enters clinical trials to enhance immune responses in solid tumors, promising ...
The Chosun Ilbo on MSN
GC Genome expands AI-based tests globally
GC Genome, which successfully completed its initial public offering (IPO) last June, is also accelerating its global market ...
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...
I've developed a weird painless growth on my neck. Do I need to get it removed? Dr Philippa Kaye answers: One of the most ...
Reliance Industries is set to disrupt the genomic diagnostics market by offering tests for under ₹1,000, significantly ...
UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive treatment called radiofrequency ablation ...
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, driven by marked molecular and clinical heterogeneity and ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase ...
Nearly a year ago, Amara Brown told The Breeze she was on vacation in Aruba, spending time with her partner, and had no idea ...
Penn Highlands DuBois has reached another milestone in care. Richard F. Latuska, MD, a board-certified gastroenterologist, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback